Thrombotic occlusion of a prosthetic Bjork-Shiley valve is a potentially fatal complication. We present the case of a male, 62 years of age, diagnosed with thrombotic occlusion of prosthetic Bjork-Shiley aortic valve approximately 17 years post implantation. A brief review of the literature focusing on potential risk factors associated with the development of this condition and currently available diagnostic modalities used for evaluation and treatment are presented.
INTRODUCTION

CASE REPORT
In 1985, a male, 62 years of age, underwent aortic and mitral valve replacement with Bjork-Shiley prostheses (both 27 mm) for rheumatic heart disease. In 1986 he suffered significant brain trauma in a motor vehicle accident. As a result, there was significant impairment in cognitive and adaptive abilities with memory loss, psychomotor retardation and impaired problem-solving skills. In 2001 he was admitted to another institution for congestive heart failure. A two-dimensional echocardiogram was performed, which revealed no abnormality of the prosthetic aortic and mitral valves. There was bilateral atrial enlargement, left ventricular hypertrophy and pulmonary hypertension with Doppler derived pulmonary systolic pressure of 75 mm Hg.
He was readmitted in August 2002 for congestive heart failure. At that time a two-dimensional echocardiogram was performed that detected stenosis of the prosthetic aortic valve. He was subsequently transferred to our hospital, a tertiary care center.
On examination there was no jugular vein distension. Chest auscultation revealed bilateral posterior basilar rates. The carotid upstroke was normal. There was a grade 2/6 systolic murmur in the lower sternal border. The opening and closing clicks of a prosthetic valve were faintly audible. There was bilateral pitting edema in the lower extremities.
The electrocardiogram showed atrial fibrillation with controlled ventricular response with right axis deviation. A chest x-ray showed cardiomegaly with increasing parenchymal opacity in both lower sides, which may have represented pneumonitis, peribronchial edema, or atelectasis. The patient's international normalized ratio (INR) on admission was 3.9.
An emergent transthoracic echocardiogram was performed and demonstrated only partial opening of the prosthetic aortic disc. Color flow imaging showed crescent flow in systole. The peak instantaneous valve gradient was calculated to be 55 mm Hg. The prosthetic mitral valve appeared to be normal. Cinefluoroscopy of the Bjork-Shiley prosthetic valve revealed an open angle of 10º (figures 1 and 2).
Thrombolytic therapy was considered to be contraindicated because of the patient's high INR. The remaining hospital course was complicated by cardiogenic shock with systolic blood pressure dropping to 70 mm Hg. There was also significant deterioration of renal function and mental faculties. A consultation with the cardiothoracic surgery team determined that the patient was a high-risk case for replacement of the stenotic prosthetic aortic valve. The patient died 5 days after admission. Thrombotic occlusion of prosthetic cardiac valves is considered one of the most serious complications associated with tilting disc mechanical valves. The overall risk of major thrombotic occlusion ranges from 1% to 8%. 1 Karp et al. estimated that the cumulative likelihood of thrombotic occlusion of Bjork-Shiley valve for aortic, mitral, and combination mitral and aortic levels is 3%, 13%, and 13%, respectively. 2 The obstruction of prosthetic valve may be caused by thrombi formation, pannus ingrowth, or a combination of these.
DISCUSSION
Thrombosis of prosthetic valves has been reported despite adequate anticoagulation. The risk of thrombosis is higher in prosthetic mitral valves than in prosthetic aortic valves. [1] [2] [3] The factors that increase the risk of thrombosis are Furthermore, the small size of the mitral annulus, decreased blood flow through the mitral valve, atrial fibrillation, left atrial enlargement and left atrial thrombosis at the time of valve replacement have all been associated with an increased risk of subsequent thrombosis of a prosthetic mitral valves. 1 The single leaflet disc prosthesis has major and minor orifices. The blood flow through the minor orifice is roughly 23%. This region is associated with decreased peak flow velocity and lower peak shear stress on the sewing rim of the Bjork-Shiley prosthesis. Which may result in pannus formation. 4 Changing the disc to concavoconvex and the orientation of the prosthetic mitral valve posteriorly increases the blood flow through the minor orifice to 30%. This reduces the risk of thrombosis. 2, 5 The initial suspicion for complications is based primarily on clinical history with subsequent confirmation by physical and laboratory examination. In a patient with new onset of congestive heart failure and nonimmunologic hematolytic anemia, attention should always be focused toward evaluation of prosthetic valves. 6 The most helpful diagnostic feature on physical examination is the change in the intensity of opening and closing clicks of the valve. The presence of systolic and diastolic murmur is not an accurate indication of valve function. 1 However, the clinical signs of valve incompetence and disappearance of the sound closure of the valve likely appear before the sign of prosthetic valve stenosis. 7 The diagnosis can be made with cineradiography, echocardiography and cardiac catheterization. Discs of a Bjork-Shiley valve, manufactured after 1975, are incorporated with radio opaque markers. Therefore, cinefluoroscopy has played an important role as a diagnostic tool for the detection of prosthetic tilting disc valve dysfunction. The decrease in the angle of the disc (normal is 60º ± 2º) and immobility of the disc can be diagnosed with considerable accuracy. 1, 7 Two-dimensional echocardiography and transesophageal echocardiography can show a density surrounding the valve and can also calculate the transvalvular gradient. Echocardiographic findings in patients with thrombotic occlusion of prosthetic valve include decreased amplitude of valve excursion, in conjunction with diminished opening and closing rates or absence of disc motion. 8 A comparison study to the previous echocardiography, especially the change in time of valve opening and closure and chamber enlargement, is helpful. 7 Besides accurately assessing stenosis and regeneration, cardiac catheterization may show a filling defect because of the thrombosis 1, 7, 9 and an excessive pressure gradient across the prosthetic valve.
Thrombotic occlusion of the prosthetic aortic valve is a medical emergency. Thrombolytic therapy for an obstructed prosthetic valve is often ineffective, especially if it is caused by pannus ingrowth. The use of thrombolytic therapy is associated with a failure rate of 16% to 18% and an acute mortality rate of 6%. 10 Thrombolytic therapy should be reserved for those patients in whom either surgery is contraindicated or associated with higher risks. If possible, patients should undergo emergency exploratory cardiotomy. During cardiotomy, there are typically two options: either the debridement of the annulus of the prosthetic valve or the replacement of the prosthetic valve.
Re-operation of prosthetic valves have resulted in high mortality; 40% with valve replacement and 8% with thrombectomy and valve rotation. [11] [12] [13] [14] Replacement of prosthetic valve should be limited to cases of extensive, circular pannus underlying the thrombus-like material, or when the primary mechanical cause (i.e., disc wear, mobile module strut, irregular ring contour) is found. 11
CONCLUSION
The diagnosis of thrombotic occlusion of Bjork-Shiley valve is suggested by clinical history and physical examination. High mortality rates associated with valve thrombosis are related to delays in diagnosis.
